Fuchs, H. F., Schmidt, H. M., Meissner, M., Brinkmann, S., Maus, M., Bludau, M., Schroeder, W., Hoelscher, A. H. and Leers, J. M. (2018). Endoscopic and histopathologic reflux-associated mucosal damage in the remnant esophagus following transthoracic esophagectomy for cancer-5-year long-term follow-up. Dis. Esophagus, 31 (1). CARY: OXFORD UNIV PRESS INC. ISSN 1442-2050

Full text not available from this repository.

Abstract

Gastroesophageal reflux is a common problem following esophagectomy and reconstruction with gastric interposition. Despite a routine prescription of proton pump inhibitors, reflux-associated mucosal damage in the remnant esophagus is frequently observed. Purpose of this study is to evaluate mucosal damage in the esophageal remnant during long-term follow-up and to compare the prevalence of this damage between the subgroups of esophageal squamous cell and adenocarcinoma. All patients undergoing transthoracic Ivor-Lewis esophagectomy were prospectively entered in our IRB approved database. All patients underwent a routine check-up program with yearly surveillance endoscopies following esophagectomy. Only patients with a complete follow-up were included into this study. Endoscopic and histopathologic mucosal changes of the remnant esophagus were analyzed in close intervals. A total of 50 patients met the inclusion criteria, consisting of 31 adenocarcinomas (AC) and 19 squamous cell carcinomas (SCC). Mucosal damage was already seen 1 year after surgery in 20 patients macroscopically (43%) and in 21 patients microscopically (45%). At 5-year follow-up the prevalence for macroscopic and microscopic damage was 55% and 60%, respectively. The prevalence of mucosal damage was higher in AC patients than in SCC patients (1y-FU: 51% [AC] vs. 28% [SCC]; 5y-FU: 68% [AC] vs. 35% [SCC], P < 0.05). Newly acquired Barrett's esophagus was seen in 10 patients (20%) with two of those patients (20%) showing histopathologic proof of neoplasia. This study shows a high prevalence of reflux-associated mucosal damage in the remnant esophagus one year out of surgery and only a moderate increase in prevalence in the following years. Mucosal damage was more frequently seen in AC patients and the occurrence of de-novo Barrett's esophagus and de-novo neoplasia was high. Endoscopic surveillance with targeted biopsies seems to be an indispensable tool to follow patients after esophagectomy appropriately.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Fuchs, H. F.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schmidt, H. M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Meissner, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Brinkmann, S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Maus, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bludau, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schroeder, W.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hoelscher, A. H.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Leers, J. M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-204321
DOI: 10.1093/dote/dox115
Journal or Publication Title: Dis. Esophagus
Volume: 31
Number: 1
Date: 2018
Publisher: OXFORD UNIV PRESS INC
Place of Publication: CARY
ISSN: 1442-2050
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
QUALITY-OF-LIFE; BARRETTS-ESOPHAGUS; CANCER; METAPLASIA; ADENOCARCINOMA; DIAGNOSIS; STOMACH; IMPACT; TIMEMultiple languages
Gastroenterology & HepatologyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/20432

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item